OXIS INTERNATIONAL, INC. is one of the oldest biotech companies in the U.S. with operations dating back to 1966. Our focus and expertise makes Oxis well positioned for active participation in the Nutraceuticals and Therapeutics market:
NUTRACEUTICALS are substances that are believed to have a beneficial overall effect on human health and include antioxidants, which have been enjoying growing consumer awareness and association with long-term health benefits. OXIS has patented the synthesis process for L-Ergothioneine, a powerful antioxidant with universal applications in over-the-counter nutraceuticals, and we are currently seeking one or more partners to commercialize this promising asset.
THERAPEUTICS are the actual remedies that can be used to treat disease. We have several therapeutic compounds that have been or are available to be licensed and include a promising anti-inflammatory in Phase II clinical trials and several therapeutic antioxidant mimics with potential applications in the treatment of neurodegenerative (Alzheimer’s and Parkinson’s), cardiovascular diseases and diabetes.